Chemomab Therapeutics Ltd.（CMMB）重大事項與業績發布
| 申報日 | 表別 | 事項 | 原文 |
|---|---|---|---|
| 2026-08-19 | 6-K | — | SEC |
| 2026-07-08 | 6-K | — | SEC |
| 2026-06-02 | 6-K | — | SEC |
| 2026-05-14 | 6-K | — | SEC |
| 2026-05-06 | 6-K | — | SEC |
| 2026-04-28 | 6-K | — | SEC |
| 2026-03-20 | 6-K | — | SEC |
| 2026-03-19 | 6-K | — | SEC |
| 2025-11-21 | 6-K | — | SEC |
| 2025-08-22 | 6-K | — | SEC |
| 2025-08-14 | 6-K | — | SEC |
| 2025-07-25 | 6-K | — | SEC |
| 2025-07-01 | 6-K | — | SEC |
| 2025-05-27 | 6-K | — | SEC |
| 2025-05-15 | 6-K | — | SEC |
| 2025-04-15 | 6-K | — | SEC |
| 2025-03-27 | 6-K | — | SEC |
| 2025-03-20 | 6-K | — | SEC |
| 2025-03-03 | 6-K | — | SEC |
| 2025-02-19 | 6-K | — | SEC |
| 2024-11-18 | 6-K | — | SEC |
| 2024-11-14 | 6-K | — | SEC |
| 2024-10-11 | 6-K | — | SEC |
| 2024-08-21 | 6-K | — | SEC |
| 2024-07-25 | 6-K | — | SEC |
| 2024-06-12 | 6-K | — | SEC |
| 2024-05-09 | 6-K | — | SEC |
| 2024-05-08 | 6-K | — | SEC |
| 2024-05-03 | 6-K | — | SEC |
| 2024-03-07 | 6-K | — | SEC |
| 2024-01-03 | 6-K | — | SEC |
資料來自 SEC EDGAR 的 8-K／6-K 申報。8-K 是美國國內發行人的重大事項揭露（Item 2.02 為業績發布）；6-K 是外國發行人（含 ADR）的對應形式。本站僅整理連結，原文一律在 SEC 網站。